All Videos Channels
  1. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    19
  2. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    1
  3. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    27
  4. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    20
  5. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    21
  6. Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    1
  7. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    18
  8. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    22
  9. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    19
  10. Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    24
  11. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    20
  12. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    17
  13. Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

    Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

    12
  14. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    21
  15. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    26
  16. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  17. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  18. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    12
  19. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    12
  20. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    21
  21. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    16
  22. 🚨 Novo Nordisk's Weight-Loss Drug Setback! 📉

    🚨 Novo Nordisk's Weight-Loss Drug Setback! 📉

    2
  23. Senate HELP committee grills Novo Nordisk on weight loss drug pricing - September 24, 2024

    Senate HELP committee grills Novo Nordisk on weight loss drug pricing - September 24, 2024

    2
    0
    71
    1
  24. Novo Nordisk and Eli Lilly Battle for a Slice of India’s Obesity Market | Vantage with Palki Sharma

    Novo Nordisk and Eli Lilly Battle for a Slice of India’s Obesity Market | Vantage with Palki Sharma

    9
  25. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    3